| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sümeyye Koç, Sedat Şen, Yüksel Terzi, Ferah Kızılay, Serkan Demir, Dürdane Bekar Aksoy, Fatma Kurtuluş, Nuray Bilge, Egemen Idilman, Cihat Uzunköprü, Serdal Güngör, Vedat Çilingir, Özlem Ethemoğlu, Cavit Boz, Haluk Gümüş, Ahmet Kasım Kılıç, Ayşin Kısabay, Levent Sinan Bir, Ömer Faruk Turan, Aysun Soysal, Mesrure Köseoğlu, Gülnur Tekgöl Uzuner, Hasan Bayındır, Sibel Canbaz Kabay, Mustafa Çam, Vildan Yayla, Hüseyin Tan, Abdülcemal Özcan, Özlem Taşkapıoğlu, Muammer Korkmaz, Yusuf Tamam, Yılmaz İnanç, Hüsnü Efendi, Dilcan Kotan, Mehmet Fatih Yetkin, Adnan Burak Bilgiç, Hikmet Saçmacı, Serpil Demirci, Yahya Çelik, Turan Poyraz, Murat Terz. Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein. Balkan medical journal. 2024-06-03. PMID:38828767. |
optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (nmosd) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin g (anti-mog-igg). |
2024-06-03 |
2024-06-05 |
Not clear |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Samira Luisa Apostolos Pereira, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Pröbstel, Cristina Granziera, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefan. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of neurology. 2024-05-23. PMID:38780377. |
grey matter atrophy and its relationship with white matter lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, and multiple sclerosis. |
2024-05-23 |
2024-05-27 |
Not clear |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Samira Luisa Apostolos Pereira, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Pröbstel, Cristina Granziera, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefan. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of neurology. 2024-05-23. PMID:38780377. |
to evaluate: (1) the distribution of gray matter (gm) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4+nmosd), and relapsing-remitting multiple sclerosis (rrms); and (2) the relationship between gm volumes and white matter lesions in various brain regions within each disease. |
2024-05-23 |
2024-05-27 |
Not clear |
| Ying Chen, Jingzi Zhangbao, Junfeng Xu, Lei Zhou, Zhiming Zhou, Chao Qua. The distinction of area postrema syndrome between MOGAD and NMOSD. Heliyon. vol 10. issue 10. 2024-05-23. PMID:38779012. |
both myelin oligodendrocyte glycoprotein-igg associated disorders (mogad) and neuromyelitis optica spectrum disorder (nmosd) are demyelinating diseases of the central nervous system. |
2024-05-23 |
2024-05-27 |
Not clear |
| Niroshan Jeyakumar, Magdalena Lerch, Russell C Dale, Sudarshini Ramanatha. MOG antibody-associated optic neuritis. Eye (London, England). 2024-05-23. PMID:38783085. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is a demyelinating disorder, distinct from multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2024-05-23 |
2024-05-27 |
Not clear |
| Aiden Haghikia, Georg Schett, Dimitrios Mougiakako. B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases. The Lancet. Neurology. vol 23. issue 6. 2024-05-17. PMID:38760099. |
neuroimmunology research and development has been marked by substantial advances, particularly in the treatment of neuroimmunological diseases, such as multiple sclerosis, myasthenia gravis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein antibody disease. |
2024-05-17 |
2024-05-27 |
Not clear |
| Nouf Alfaidi, Salama Karmastaji, Alexandria Matic, Vera Bri. FcRn Inhibitor Therapies in Neurologic Diseases. CNS drugs. 2024-05-09. PMID:38724842. |
numerous clinical trials are currently underway to investigate their effectiveness, safety, and tolerability in various neurological conditions, including myasthenia gravis and other neurological disorders such as chronic inflammatory demyelinating polyneuropathy, myositis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. |
2024-05-09 |
2024-05-27 |
Not clear |
| Ramakrishna Prithviraj, Bidisha Banerjee, Ullas V Acharya, Muhammed Hafis, Sruthi Sashidhara. Clinico-radiologic Spectrum and Outcome of Pediatric Acquired Demyelinating Disorders of Central Nervous System: A Retrospective Indian Tertiary Care Hospital Cohort. Neuropediatrics. 2024-05-07. PMID:38641336. |
we describe clinico-radiologic spectrum, outcomes, and comparison of the groups: acute disseminated encephalomyelitis (adem), neuromyelitis optica spectrum disorder (nmosd), clinically isolated syndrome (cis), multiple sclerosis (ms), and myelin oligodendrocyte glycoprotein antibody-associated disorders (mogad). |
2024-05-07 |
2024-05-27 |
Not clear |
| Laura Cacciaguerra, Omar Abdel-Mannan, Dimitrios Champsas, Kshitij Mankad, Karl N Krecke, John J Chen, Stephanie B Syc-Mazurek, Vyanka Redenbaugh, Alfonso S Lopez-Chiriboga, Cristina Valencia-Sanchez, Cheryl Hemingway, Jan-Mendelt Tillema, Olga Ciccarelli, Sean J Pittock, Yael Hacohen, Eoin P Flanaga. Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease. Neurology. vol 102. issue 10. 2024-05-06. PMID:38710000. |
we evaluated intra-attack lesion dynamics in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) vs multiple sclerosis (ms) and aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder (aqp4+nmosd). |
2024-05-06 |
2024-05-27 |
Not clear |
| Jun Sun, Min Guo, Li Chai, Siyao Xu, Yuerong Lizhu, Yuna Li, Yunyun Duan, Xiaolu Xu, Shan Lv, Jinyuan Weng, Kuncheng Li, Fuqing Zhou, Haiqing Li, Yongmei Li, Xuemei Han, Fu-Dong Shi, Xinghu Zhang, Decai Tian, Zhizheng Zhuo, Yaou Li. Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases. Brain : a journal of neurology. 2024-05-04. PMID:38703370. |
gray matter (gm) atrophies were observed in multiple sclerosis, neuromyelitis optica spectrum disorders (both anti-aquaporin-4 antibody-positive [aqp4+], and -negative [aqp4-] subtypes nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-05-04 |
2024-05-07 |
human |
| Alessia Bianchi, Rosa Cortese, Ferran Prados, Carmen Tur, Baris Kanber, Marios C Yiannakas, Rebecca Samson, Floriana De Angelis, Lise Magnollay, Anu Jacob, Wallace Brownlee, Anand Trip, Richard Nicholas, Yael Hacohen, Frederik Barkhof, Olga Ciccarelli, Ahmed T Toos. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England). 2024-04-22. PMID:38646958. |
optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease. |
2024-04-22 |
2024-04-26 |
Not clear |
| Alessia Bianchi, Rosa Cortese, Ferran Prados, Carmen Tur, Baris Kanber, Marios C Yiannakas, Rebecca Samson, Floriana De Angelis, Lise Magnollay, Anu Jacob, Wallace Brownlee, Anand Trip, Richard Nicholas, Yael Hacohen, Frederik Barkhof, Olga Ciccarelli, Ahmed T Toos. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England). 2024-04-22. PMID:38646958. |
optic neuritis (on) is a common feature of inflammatory demyelinating diseases (idds) such as multiple sclerosis (ms), aquaporin 4-antibody neuromyelitis optica spectrum disorder (aqp4 + nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-04-22 |
2024-04-26 |
Not clear |
| Lucia Campetella, Macarena Villagrán-García, Antonio Farina, Marie Benaiteau, Raffaele Iorio, Paolo Calabresi, Alberto Vogrig, Salvatore Versace, Nicolás Lundahl Ciano-Petersen, Elodie Bicilli Brotelle, Pierre Branger, Clotilde Verlut, Sophie Langner-Lemercier, Alexandre Leclancher, Coline Duwicquet, Mahmoud Charif, Philippe Kerschen, Nicolas Capet, Dimitri Renard, Eve Chanson, Marie Rafiq, Louise Tyvaert, Bastien Joubert, François Cotton, Jérôme Honnorat, Sergio Muñiz-Castrill. Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies. Journal of neuroimmunology. vol 390. 2024-04-22. PMID:38648696. |
in a systematic review including patients with other neuroglial antibodies, cst hyperintensity was reported in 110 with neuromyelitis optica (94%), myelin oligodendrocyte glycoprotein-associated disease (2%), ma2-antibody (3%) and gad65-antibody paraneoplastic neurological syndrome (1%). |
2024-04-22 |
2024-04-26 |
Not clear |
| Nanthaya Tisavipat, Hui Y Juan, John J Che. Monoclonal antibody therapies for aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. vol 38. issue 1. 2024-04-17. PMID:38628414. |
monoclonal antibody therapies for aquaporin-4-immunoglobulin g-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2024-04-17 |
2024-04-19 |
Not clear |
| Noah J Spillers, Patrick M Luther, Norris C Talbot, Evan J Kidder, Connor A Doyle, Salim C Lutfallah, Alyssa G Derouen, Sridhar Tirumala, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D Kaye, Giustino Varrass. A Comparative Review of Typical and Atypical Optic Neuritis: Advancements in Treatments, Diagnostics, and Prognosis. Cureus. vol 16. issue 3. 2024-04-15. PMID:38618469. |
herein, we examine the differences in presentation, pathophysiology, and treatments of typical on causes, like multiple sclerosis (ms), and atypical causes such as neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein (mog)-immunoglobulin g (igg) on. |
2024-04-15 |
2024-04-17 |
Not clear |
| S Jarius, M Ringelstein, K Schanda, K Ruprecht, M Korporal-Kuhnke, A Viehöver, M W Hümmert, P Schindler, V Endmayr, M Gastaldi, C Trebst, D Franciotta, O Aktas, R Höftberger, J Haas, L Komorowski, F Paul, M Reindl, B Wildeman. Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity-a potential diagnostic pitfall in patients with MOG-EM/MOGAD. Journal of neurology. 2024-04-12. PMID:38609667. |
myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (mog-em; also termed mog antibody-associated disease, mogad) is the most important differential diagnosis of both multiple sclerosis and neuromyelitis optica spectrum disorders. |
2024-04-12 |
2024-04-15 |
Not clear |
| Amna Siddiqui, Dylan Ross, Ronak H Jani, Vikram C Prabhu, Shelly Lo, Derek A Wainwright, Stasia Rouse, Tamer Refaat, Yirong Zhu, Jigisha P Thakka. Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clinical & experimental neuroimmunology. vol 15. issue 1. 2024-04-10. PMID:38595690. |
cerebrospinal fluid was positive for neuromyelitis optica immunoglobulin g antibody anti-aquaporin-4, and autoimmune myelopathy panel was positive for myelin oligodendrocyte glycoprotein antibody. |
2024-04-10 |
2024-04-12 |
Not clear |
| Amna Siddiqui, Dylan Ross, Ronak H Jani, Vikram C Prabhu, Shelly Lo, Derek A Wainwright, Stasia Rouse, Tamer Refaat, Yirong Zhu, Jigisha P Thakka. Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clinical & experimental neuroimmunology. vol 15. issue 1. 2024-04-10. PMID:38595690. |
this case shows that these antibodies can occur concurrently and cause clinical features, such as both neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease, in a patient with a singular type of cancer. |
2024-04-10 |
2024-04-12 |
Not clear |
| Miyo K Chatanaka, Lisa M Avery, Maria D Pasic, Shanthan Sithravadivel, Dalia Rotstein, Catherine Demos, Rachel Cohen, Taron Gorham, Mingyue Wang, Martin Stengelin, Anu Mathew, George Sigal, Jacob Wohlstadter, Ioannis Prassas, Eleftherios P Diamandi. The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies. Clinical proteomics. vol 21. issue 1. 2024-04-08. PMID:38580905. |
certain demyelinating disorders, such as neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) exhibit serum autoantibodies against aquaporin-4 (αaqp4) and myelin oligodendrocyte glycoprotein (αmog). |
2024-04-08 |
2024-04-10 |
Not clear |
| Eun Bin Cho, Ju-Hong Min, Patrick Waters, Miyoung Jeon, Eun-Seon Ju, Ho Jin Kim, Su-Hyun Kim, Ha Young Shin, Sa-Yoon Kang, Young-Min Lim, Sun-Young Oh, Hye Lim Lee, Eunhee Sohn, Sang-Soo Lee, Jeeyoung Oh, Sunyoung Kim, So-Young Huh, Joong-Yang Cho, Jin Myoung Seok, Byung-Jo Kim, Byoung Joon Ki. Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder. Frontiers in immunology. vol 15. 2024-04-05. PMID:38576611. |
myelin oligodendrocyte glycoprotein antibody (mog) immunoglobulin g (igg)-associated disease (mogad) has clinical and pathophysiological features that are similar to but distinct from those of aquaporin-4 antibody (aqp4-igg)-positive neuromyelitis optica spectrum disorders (aqp4-nmosd). |
2024-04-05 |
2024-04-07 |
Not clear |